| Ms Donna Maria Mcfadden, OTR/L | |
|
2200 Fort Roots Dr # 117/nlr, North Little Rock, AR 72114-1709 | |
| (501) 257-2990 | |
| Not Available |
| Full Name | Ms Donna Maria Mcfadden |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 2200 Fort Roots Dr # 117/nlr, North Little Rock, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144302092 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OTR 346 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Donna Maria Mcfadden, OTR/L 7426 Hwy 365 South, Sweet Home, AR 72164 Ph: (501) 490-2576 | Ms Donna Maria Mcfadden, OTR/L 2200 Fort Roots Dr # 117/nlr, North Little Rock, AR 72114-1709 Ph: (501) 257-2990 |
News Archive
Debate among public health professionals over approaches to tobacco and nicotine regulation has intensified with the rise of vaping in the form of electronic cigarettes (or e-cigarettes) and tobacco heat-not-burn products.
Scientists from the University of South California (USC) report the development of a novel technique to image living cells in greater detail and increased clarity. The study, published in the journal Nature Communications, describes a technology which can confer the ability to actually see things going wrong – a great advantage in the study of health and disease.
People who have contact with other social groups are more likely to be committed to social justice. However, an international study led by the University of Zurich has shown that for this to be the case, power relations and discrimination must be actively addressed and group-specific needs must be met.
Diffusion Pharmaceuticals LLC announced today that trans sodium crocetinate (TSC), the company's lead drug candidate, has been granted an Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of primary brain cancer, also known as glioblastoma multiforme or GBM.
Researchers at the University of Hertfordshire have developed a new structural model of a protein, which makes it possible to develop more effective drugs to target diseases such as cancer, heart disease and influenza.
› Verified 1 days ago
Mrs. Stacy Lynn Alberson, OTR L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 119 West H Ave, North Little Rock, AR 72116 Phone: 501-772-3211 Fax: 501-771-7648 | |
Adeline S. Teo, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4901 N Shore Dr, North Little Rock, AR 72118 Phone: 501-791-3331 Fax: 501-791-0294 | |
Ms. Malinda Marie Zionce, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 17123 Mac Arthur Dr, North Little Rock, AR 72118 Phone: 501-514-5205 | |
Annemarie Beck, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 119 W H Ave, North Little Rock, AR 72116 Phone: 501-772-3224 Fax: 501-771-7648 | |
Tessa Monique Davis, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 21 Gunstock Lane, North Little Rock, AR 72120 Phone: 870-219-6565 | |
Mary Kathryn Mcgee, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5532 Jfk Blvd, North Little Rock, AR 72116 Phone: 501-588-3211 Fax: 501-353-2599 | |
Martha Blodgett, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5532 Jfk Blvd, North Little Rock, AR 72116 Phone: 501-588-3211 Fax: 501-353-2599 |